Emergent BioSolutions Inc/ US29089Q1058 /
| 2024-04-26 9:59:33 PM | Chg. -0.05 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.93USD | -2.28% | 15,056 Turnover: 29,118.76 |
-Bid Size: - | -Ask Size: - | 100.23 mill.USD | - | - |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | - | 209 | 241.8000 | 264.2000 | 313.9790 | ||||||
| Intangible Assets | - | 0.0000 | 0.0000 | 30.1000 | 58.3440 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | 513.0870 | ||||||
| Inventories | - | 14.7000 | 15.2000 | 14.6000 | 65.6740 | ||||||
| Accounts Receivable | - | 74.2000 | 96 | 60.6000 | 58.8340 | ||||||
| Cash and Cash Equivalents | - | 143.9000 | 141.7000 | 179.3000 | 280.4990 | ||||||
| Current Assets | - | 254.4000 | 263.3000 | 273.1000 | 432.1750 | ||||||
| Total Assets | - | 546.9000 | 564.2000 | 626.6000 | 945.2620 | ||||||
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | - | 40.5000 | 31.3000 | 27.5000 | 40.9300 | ||||||
| Long-term debt | - | - | - | - | 251 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | - | - | - | 1.4900 | - | ||||||
| Liabilities | - | 130.1000 | 122.1000 | 137.5000 | 392.0610 | ||||||
| Share Capital | - | .0360 | .0360 | .0370 | .0380 | ||||||
| Total Equity | - | 416.7000 | 442.1000 | 489.2000 | 553.2010 | ||||||
| Minority Interests | - | 2.5000 | .8000 | -.5000 | - | ||||||
| Total liabilities equity | - | 546.9000 | 564.2000 | 626.6000 | 945.2620 | ||||||
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 286.2000 | 273.4000 | 281.9000 | 312.7000 | 450.1380 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 73.6000 | 32.1000 | 30 | 42.8000 | 58.0560 | ||||||
| Interest Income | .8000 | .1000 | .1000 | .1000 | -7.9200 | ||||||
| Income Before Taxes | 73.4000 | 31.9000 | 32.1000 | 43.4000 | 53.0620 | ||||||
| Income Taxes | 26.2000 | 15.8000 | 13.9000 | 13.1000 | 16.3210 | ||||||
| Minority Interests Profit | 4.5000 | 6.9000 | 5.4000 | .9000 | - | ||||||
| Net Income | 51.7000 | 23 | 23.5000 | 31.1000 | 36.7410 | ||||||
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 98 | 12.2000 | 39.6000 | 97 | 112.3180 | ||||||
| Cash Flow from Investing Activities | -23.5000 | -54 | -40.1000 | -67.9000 | -210.0520 | ||||||
| Cash Flow from Financing | -8.4000 | 16.7000 | -1.8000 | 8.6000 | 198.8740 | ||||||
| Decrease / Increase in Cash | 66.1000 | -25.1000 | -2.2000 | 37.7000 | 101.1610 | ||||||
| Employees | 767 | 811 | 877 | 1,353 | 1,280 | ||||||
